|05/15/17||ViewRay Reports First Quarter 2017 Financial Results|
|Reiterates 2017 Financial Guidance
CLEVELAND, May 15, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2017.
First Quarter 2017 Highlights:
Received new orders for MRIdian Linac Systems, totaling $12.3 million, compared to orders totaling $11.2 million in Q1 2016
Received orders totaling $5.8 million to upgrade installed MRIdian Cobalt Systems to Linac Systems
Total backlog grew to $144.9 million, a... |
|05/15/17||Compelling Early Pancreatic Cancer Data with ViewRay's MRIdian System Presented at ESTRO 36|
|Presentations Also Highlighted Speed and Benefit of On-Table Adaptive Therapy in Routine Clinical Use
CLEVELAND, May 15, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today highlights from ESTRO 36, the annual meeting of the European Society for Radiotherapy and Oncology, which featured broad clinical experience with the company's MRIdian System, including compelling early data on its use in pancreatic cancer.
A presentation by Sasa Mutic, Ph.D., from Was... |
|05/10/17||ViewRay Announces Conference Call and Webcast of First Quarter 2017|
|Financial Results to be Held on May 15, 2017
CLEVELAND, May 10, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2017 financial results, which will take place on Monday, May 15, 2017 after market close.
ViewRay will hold a conference call on Monday, May 15, 2017 at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. The dial-in numbers are (844) 277-1426 for domestic callers and (336) 525-7129 for international callers. ... |
|05/02/17||ViewRay Showcases World's First Commercially Available MRI-Guided Linac System at Leading European Radiation Oncology Meeting|
|Clinical Presentations Highlight Benefits of MRI-Guidance for Pancreatic, Gastrointestinal, and Prostate Cancers
Cancer Survivor Bibian Mentel, MRIdian Patient and Gold Medal Paralympian, Shares Her Story
CLEVELAND, May 2, 2017 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company will showcase its next generation MRI-guided radiation therapy solution, MRIdian Linac, at ESTRO 36, the annual meeting of the European Society for Radiotherapy and Oncology, being held Ma... |